Ruf Wolfram
Department of Immunology, The Scripps Research Institute, La Jolla, CA, USA.
Crit Care Med. 2004 May;32(5 Suppl):S287-92. doi: 10.1097/01.ccm.0000126364.46191.12.
To discuss recent studies addressing the relationship between protease-activated receptor signaling, coagulation, and inflammation.
This review article covers relevant original articles published until October 2003 dealing with animal models, clinical trial data, and in vitro experiments.
Although activation of protease-activated receptors has been implicated in the proinflammatory effects of the coagulation cascade, current data provide evidence that protease-activated receptor signaling plays a more complex role in the regulation of inflammation and endothelial homeostasis. Sensitive assays for coagulation activation have provided clear evidence that targeting the coagulation pathway effectively reduces the coagulopathy in sepsis. However, the effect of these anticoagulant agents on sepsis-associated inflammation is less clear. Further insight into this question will require the development or use of additional biomarkers for assessing pharmacologic interference with coagulation-related cell-signaling pathways.
探讨近期关于蛋白酶激活受体信号传导、凝血与炎症之间关系的研究。
这篇综述文章涵盖了截至2003年10月发表的涉及动物模型、临床试验数据和体外实验的相关原创文章。
尽管蛋白酶激活受体的激活与凝血级联反应的促炎作用有关,但目前的数据表明,蛋白酶激活受体信号传导在炎症调节和内皮稳态中发挥着更为复杂的作用。凝血激活的敏感检测方法已提供明确证据,表明针对凝血途径可有效减轻脓毒症中的凝血病。然而,这些抗凝剂对脓毒症相关炎症的影响尚不清楚。要进一步深入了解这个问题,需要开发或使用额外的生物标志物来评估对凝血相关细胞信号通路的药物干预。